We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIT
901
DELISTED
CIT Group Inc.
CIT
| $559K | ﹤0.01% |
+26,965
| New | +$521K |
|
902
GoDaddy
GDDY
$12.3B
| $557K | ﹤0.01% |
7,600
+971
| +15% | +$69.7K |
|
903
TD Synnex
SNX
$19.4B
| $556K | ﹤0.01% |
9,280
+3,164
| +52% | +$148K |
|
904
Simpson Manufacturing
SSD
$7.98B
| $556K | ﹤0.01% |
6,586
+3,317
| +101% | +$245K |
|
|
PRNB
905
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $555K | ﹤0.01% |
9,275
+3,681
| +66% | +$227K |
|
906
Green Dot
GDOT
$753M
| $550K | ﹤0.01% |
+11,200
| New | +$379K |
|
|
PDM
907
Piedmont Realty Trust
PDM
$1.22B
| $550K | ﹤0.01% |
33,090
+11,399
| +53% | +$190K |
|
908
Opko Health
OPK
$921M
| $549K | ﹤0.01% |
161,088
+46,863
| +41% | +$105K |
|
909
COPT Defense Properties
CDP
$4.31B
| $548K | ﹤0.01% |
21,612
+4,684
| +28% | +$117K |
|
910
Steel Dynamics
STLD
$35.6B
| $548K | ﹤0.01% |
20,986
+5,907
| +39% | +$148K |
|
911
Akebia Therapeutics
AKBA
$327M
| $547K | ﹤0.01% |
40,300
+17,001
| +73% | +$176K |
|
|
RDFN
912
DELISTED
Redfin
RDFN
| $547K | ﹤0.01% |
+13,042
| New | +$344K |
|
913
Cathay General Bancorp
CATY
$4.2B
| $545K | ﹤0.01% |
20,714
+8,644
| +72% | +$220K |
|
914
KB Home
KBH
$3.48B
| $545K | ﹤0.01% |
+17,767
| New | +$489K |
|
|
NVRO
915
DELISTED
NEVRO CORP.
NVRO
| $545K | ﹤0.01% |
+4,564
| New | +$541K |
|
916
Alkermes
ALKS
$8.82B
| $542K | ﹤0.01% |
27,928
+3,361
| +14% | +$54.6K |
|
917
Emergent Biosolutions
EBS
$375M
| $539K | ﹤0.01% |
+6,814
| New | +$508K |
|
918
Agree Realty
ADC
$9.68B
| $535K | ﹤0.01% |
+8,137
| New | +$519K |
|
919
Starwood Property Trust
STWD
$6.12B
| $534K | ﹤0.01% |
35,723
+3,466
| +11% | +$46.7K |
|
920
Generac Holdings
GNRC
$11.9B
| $533K | ﹤0.01% |
4,369
-1,688
| -28% | -$178K |
|
921
Ally Financial
ALLY
$13.1B
| $531K | ﹤0.01% |
26,770
+2,483
| +10% | +$42.2K |
|
|
ENV
922
DELISTED
ENVESTNET, INC.
ENV
| $531K | ﹤0.01% |
+7,217
| New | +$472K |
|
|
AMED
923
DELISTED
Amedisys
AMED
| $530K | ﹤0.01% |
2,669
-928
| -26% | -$173K |
|
924
Hanover Insurance
THG
$7.63B
| $530K | ﹤0.01% |
5,226
+1,278
| +32% | +$125K |
|
925
MasTec
MTZ
$26.7B
| $529K | ﹤0.01% |
+11,787
| New | +$447K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.